GSK Sells Rights to Drug Candidate to Alfasigma for Up to $690 Million

3 months ago 51
Under the deal, Alfasigma volition summation rights to develop, manufacture and commercialize linerixibat.
Read Entire Article
  1. Homepage
  2. Health
  3. GSK Sells Rights to Drug Candidate to Alfasigma for Up to $690 Million

Related

'I've never been this good' – revolutionary immune reset puts lupus in remission

'I've never been this good' – revolutionary immune reset put...

16 hours ago 1
'I spent uni savings on getting my teeth fixed' - how NHS dentist shortage is costing a fortune

'I spent uni savings on getting my teeth fixed' - how NHS de...

16 hours ago 1
Meningitis B vaccine to be offered to a million young people

Meningitis B vaccine to be offered to a million young people...

16 hours ago 1

Popular

U.S. Forest Service to Open Millions of Acres to Off-Road Vehicles

U.S. Forest Service to Open Millions of Acres to Off-Road Ve...

6 days ago 13
Judge Says Trump Officials Must Restart Asylum and Immigration Processing

Judge Says Trump Officials Must Restart Asylum and Immigrati...

6 days ago 11
Former Channel 4 News presenter Jon Snow reveals Alzheimer's disease diagnosis

Former Channel 4 News presenter Jon Snow reveals Alzheimer's...

6 days ago 11
Surgeons use new AI tool during live operation in UK-first

Surgeons use new AI tool during live operation in UK-first

6 days ago 11
President Trump said he wants Bill Pulte, his incoming acting director of national intelligence, to begin firing a large number of employees as part of a shake-up of the U.S. intelligence community

President Trump said he wants Bill Pulte, his incoming actin...

6 days ago 10
About Us · Contact Us · Privacy Policy ·

© DISQUS CLUB 2026. All rights are reserved